Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Tetraphase Pharmaceuticals, Inc. (TTPH) and Encourages TTPH Investors to Contact the Firm
January 28, 2019 21:45 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Tetraphase Pharmaceuticals, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tetraphase, GDS Holdings, and Sinclair and Encourages Investors to Contact the Firm
September 13, 2018 18:59 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Tetraphase Pharmaceuticals,...
Tetraphase Pharmaceuticals Appoints Kam Unninayar as Chief Financial Officer
October 16, 2017 09:00 ET
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. – TTPH
March 04, 2016 15:43 ET
|
The Rosen Law Firm PA
NEW YORK, March 04, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Tetraphase...